MELI three-lens brief
Evidence-based stock research on MELI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.09% yesterday. · Negative free cash flow last quarterly (-$4.10B).
- Moved +2.09% yesterday.
- Outperforming SPY by 8.4pp over 30 days.
- Analyst mean target $2208.63 — 20% above current (24 analysts).
- Negative free cash flow last quarterly (-$4.10B).
- Earnings scheduled 2026-08-05.
MELI closed at $1845.59 (+2.09%) as of 2026-07-10. Market cap: $93.57B. P/E (trailing) 48.6. Price is above the 50-day MA and below the 200-day MA. Positives: moved +2.09% yesterday.; outperforming SPY by 8.4pp over 30 days.. Concerns: negative free cash flow last quarterly (-$4.10B).. Last quarter: Revenue $8.85B, net income $417.00M, free cash flow -$4.10B. Watching for: 2026-08-05 earnings release (25 days out).
Why three lenses on MELI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MELIacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MELI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MELI brief"></iframe>